obscure request. hopefully this data is easy to come by !!
I would say this should be easy to work around.. though I am puzzled by the wording...
is it that they need more information - to adequately assess, the systemic exposure to NUZ?
to me it seems like they tried really hard to pick something? maybe 'somebody' just wanted in at a discount.
keen for the webinar where hopefully they can express this better than my current interpretation.
great news 'NO safety concerns' in the advice..
GLTAH
Ann: FDA Guidance on NUZ-001 IND Application, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $31.76K | 188.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29214 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 59381 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |